Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Myriad Genetics (MYGN) over the last 16 years, with Q3 2025 value amounting to $108.3 million.

  • Myriad Genetics' Accumulated Expenses fell 260.79% to $108.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.3 million, marking a year-over-year decrease of 260.79%. This contributed to the annual value of $119.0 million for FY2024, which is 447.76% up from last year.
  • As of Q3 2025, Myriad Genetics' Accumulated Expenses stood at $108.3 million, which was down 260.79% from $100.6 million recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Accumulated Expenses ranged from a high of $164.3 million in Q2 2023 and a low of $83.1 million during Q1 2021
  • In the last 5 years, Myriad Genetics' Accumulated Expenses had a median value of $108.3 million in 2025 and averaged $113.9 million.
  • As far as peak fluctuations go, Myriad Genetics' Accumulated Expenses surged by 14954.13% in 2021, and later plummeted by 4773.28% in 2022.
  • Over the past 5 years, Myriad Genetics' Accumulated Expenses (Quarter) stood at $161.7 million in 2021, then crashed by 41.68% to $94.3 million in 2022, then increased by 20.78% to $113.9 million in 2023, then grew by 4.48% to $119.0 million in 2024, then fell by 8.99% to $108.3 million in 2025.
  • Its last three reported values are $108.3 million in Q3 2025, $100.6 million for Q2 2025, and $112.1 million during Q1 2025.